Home/ Stocks/ PEPG

PepGen Inc. Common Stock

PEPG XNAS

$2.85 +0.44 (+18.19%) ▲ 15-min delayed

Open

$2.48

High

$2.88

Low

$2.44

Volume

3.22M

Market Cap

$166.92M

About PepGen Inc. Common Stock

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 57 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$0	$-17,763,000	$-0.26
FY 2025	$0	$-89,655,000	$-2.12
Q3 2025	$0	$-18,026,000	$-0.52
Q2 2025	$0	$-23,087,000	$-0.70

Related Market News

No specific coverage for PEPG yet. Check out our latest market news or earnings calendar.

Get PEPG Alerts

Stay ahead with breaking news, price alerts, and expert analysis on PepGen Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.